Michelle Bufano is a Partner at the Firm, with the majority of her practice focused in the areas of entrepreneurial law and litigation for corporate clients.

Litigation Experience

Ms. Bufano has been a litigator for almost 25 years, primarily representing corporations.  While her focus is in the area of products liability law, she also has vast experience assisting businesses in other areas of commercial litigation.

Specifically, Ms. Bufano has represented pharmaceutical and medical device companies, as well as automobile manufacturers and other types of consumer goods manufacturers in complex products liability and mass tort litigation, including class actions, multi-district litigations and coordinated proceedings in state courts.  She has represented clients in litigations involving prescription and over-the-counter drugs, medical devices such as catheters and knee and hip implants, cosmetic and wellness products, automobile brakes and engines and household items made from plastics.  In addition, Ms. Bufano has significant experience in other substantive areas of complex commercial litigation, having represented clients in a variety of breach of contract contexts and other business disputes.

Tort Liability Counseling Experience

Ms. Bufano also utilizes her extensive products liability litigation experience to also counsel clients on various issues relating to tort liability.  She has experience advising on potential tort liabilities and risks in connection with the due diligence process for corporate purchasers.  She also counsels hedge funds and other potential investors with respect to potential tort issues regarding target acquisitions.

Additionally, Ms. Bufano counsels clients on potential tort liabilities relating to content-based materials, particularly within the regulatory context.  She also advises foreign corporations on potential regulatory issues, including those relating to food products that are subject to the jurisdiction of the U.S. Food and Drug Administration.

Following law school, Ms. Bufano served as a law clerk to the Honorable Martin L. Greenberg in New Jersey Superior Court.

Entrepreneurial Law

Inspired by the strong women around her, Ms. Bufano recently started to focus on providing legal services to female entrepreneurs, founders, leaders and investors.  She leverages her almost 25 years of litigation experience to help entrepreneurs take the steps necessary to control and manage risk.

Michelle also is the mother of two independent, strong daughters, who believe that they can achieve anything.  And they will.

  • U.S District Court, Southern District of New York
  • U.S District Court, Eastern District of New York
  • U.S. District Court, District of New Jersey
  • New York
  • New Jersey
Professional Activities

MEMBERSHIPS: Data Privacy & Security Compliance Certificate Program, Seton Hall School of Law (2021); American Bar Association (Vice-Chair of Section of Science & Technology Law Committee, Biotechnology, Healthcare Technology, and Medical Devices (BHTMD) Committee (2019-2020); New Jersey State Bar Association; The Foundation of the International Association of Defense Counsel (Member); Defense Research Institute (Drug and Medical Device Committee); New Jersey Civil Justice Institute (Legal Advisory Board); Law Journal News Product Liability Law & Strategy Newsletter (Member, Board of Editors, 2008 through 2017); National Trial Advocacy College, University of Virginia School of Law (Graduate, 2001); William J. Brennan, Jr. Inn of Court (Graduate, 1999-2001)

HONORS: Recognized in New Jersey and New York Super Lawyers in the area of Class Action/Mass Torts; Previously selected for the New Jersey Law Journal’s “40 Under 40” series; Recipient, Project for Attorney Retention, Work-Life Balance Award (2009)

Speaking Engagements
  • Presenter, "Understanding How New Rule 702 Amendments Will Impact the Future Admissibility of Expert Testimony," American Conference Institute's 27th Annual Drug & Medical Device Litigation Conference (December 6, 2022)
  • Presenter, "Updates in Products Liability Law," NJCJI's 2021 Fall Legal Forum (October 12, 2021)
  • Presenter, "State of the Union on Preemption: Examining the Continued Aftermath of Albrecht and the Latest Developments in Medical Device Preemption Efforts," American Conference Institute’s 25th Annual Conference on Drug & Medical Device Litigation (December 8, 2020)
  • Presenter, "In the Aftermath of Albrecht: Implications of the Supreme Court’s Ruling on Preemption for Pharmaceutical Products Liability Litigation," American Conference Institute's 24th Annual Conference on Drug & Medical Device Litigation Conference (December 10, 2019)
  • Co-Presenter, “Deposition Toolkit,” America Bar Association’s 2019 Environmental & Energy, Mass Torts and Products Liability Committees’ Joint CLE Seminar (January 11, 2019)
  • Co-Presenter, “Predicting Risk and Examining the Intersection of Traditional Principles of Product Liability Laws with Digital Health and 3D Printing,” American Conference Institute’s 23rd Annual Conference on Drug & Medical Device Litigation (November 29, 2018)
  • Co-Presenter, “Products Liability and the Internet of Things,” Bloomberg Webinar (September 13, 2018)
  • Co-Presenter, “NJ Supreme Court: Landmark Decision on Standards for Expert Testimony,” New Jersey Civil Justice Institute Policy Teleforum (August 1, 2018)
  • Presenter, “Revisiting the Role of the Learned Intermediary Doctrine," New Jersey Defense Association & Association of Corporate Counsel New Jersey's 2016 Products Liability Seminar: Something for Everyone - A Look at Hot Products Topics in the Early 21st Century (September 23, 2016)
  • "Is Daubert Now A Dirty Word?," American Bar Association (March 21, 2022)

  • Three-Part Article Series for the National Law Journal on Adapting to Remote Proceedings in the Post-Pandemic Era
  • "Assessing Potential Risk: Due Diligence for Acquisition of Product Manufacturers," New Jersey Law Journal (December 11, 2019)

  • "What New Calif. Law Means For Connected Medical Devices," Law360 (October 5, 2018)

  • "'Accutane' Appeal Presents Opportunity for NJ to Adopt 'Daubert'," New Jersey Law Journal (December 11, 2017)

  • "NJ Supreme Court Takes Us Back in Time on Tort Statute of Limitations," New Jersey Law Journal (February 20, 2017)

  • "Product Liability & Toxic Tort Litigation: Recent ‘Reglan’ Decision Chips Away at Preemption," New Jersey Law Journal (December 12, 2016)

  • "The Foreign Plaintiff Problem," Bloomberg BNA's Product Safety & Liability Reporter (December 5, 2016)

  • “Getting Serious About Senseless Claims,” New Jersey Law Journal (December 9, 2015)

  • “New Limitations on The Discovery Rule in Products Liability Cases,” New Jersey Law Journal (December 17, 2012)

  • “Irreconcilable Differences in Prescription Drug Liability Cases,” New Jersey Law Journal (December 12, 2011)

  • “Applying the Doctrine of Forum Non Conveniens to Out-of-State Plaintiffs in Mass Tort Cases,” New Jersey Law Journal (November 22, 2012)

  • “The Importance of the Early Disposition of Baseless Claims in New Jersey Products Liability Mass Tort Litigation,” New Jersey Lawyer (August 2011)

  • “Practice Tip: Keys to Successful Negotiation of Clinical Trial Agreements,” LJN’s Product Liability Law & Strategy (December 2009)

  • “Avoiding Dysfunctional Litigation,” LJN’s Product Liability Law & Strategy (April 2009)

  • “Fight For Your Right To Ex Parte,” New Jersey Law Journal (December 8, 2009)

  • “Medical Device Manufacturers Can Breathe Easier,” New Jersey Law Journal (December 15, 2008)

  • “Hope at Last for Drug Manufacturers Sued in NJ?” Law360 (November 24, 2008)

  • “The Learned Intermediary Doctrine,” LJN’s Product Liability Law & Strategy (August 2008)

  • “The Foreign Plaintiff,” New Jersey Law Journal (December 17, 2007)